Last reviewed · How we verify

NCT03853967

Lung Cancer Screening by Low Dose CT Scan in a French Department (DEP KP80)

Status unknown NA Last updated 26 February 2019
What this trial tests

NA trial testing Low dose CT scan in Lung Cancer Screening in 1,307 participants. Status unknown.

Timeline
15 May 2016
Primary endpoint
15 May 2020
15 May 2021

Quick facts

Lead sponsorCentre Hospitalier d'Abbeville
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposescreening
Enrollment1,307
Start date15 May 2016
Primary completion15 May 2020
Estimated completion15 May 2021
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Centre Hospitalier d'Abbeville

Who can join

Adults 55 to 74, any sex, with Lung Cancer Screening. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Lung cancer is the leading cause of cancer death worldwide. The aims of this study were to assess the feasibility and effectiveness of a lung cancer screening pilot program with LD CT scan in a French department (Somme). DEP KP80 was a single-arm, prospective study started in May 2016. The inclusion criteria were those of the National Lung Screening Trial. An annual LD CT scan was scheduled and 2 rounds were planned. Smoking cessation was encouraged as part of the protocol. Subjects were selected by General Practitioner or Pneumologist who checked the inclusion criteria and prescribed the CT scan.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Lung cancer screening by low-dose CT scan in France: final results of the DEP KP80 study after three rounds.
    Leleu O, Storme N, Basille D, Auquier M, et al · · 2024 · cited 3× · PMID 39396424 · DOI 10.1016/j.ebiom.2024.105396

Verify or expand the search:

Other recruiting trials for Lung Cancer Screening

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03853967.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing